|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Rebif (Interferon Beta-1A). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (1568)
Cases resulting in a serious event (1517)
Cases resulting in death (103)
Cases resulting in life threatening events (45)
Cases resulting in hospitalization (913)
Cases resulting in disability (43)
Cases resulting in other serious reactions (692)
Below is a sample of reports where side effects / adverse reactions may be related to Rebif (Interferon Beta-1A). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Rebif (Interferon Beta-1A)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Nephrolithiasis
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 28 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 28 year old female
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Convulsion
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 43 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 43 year old female, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Uterine Polyp
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Provigil; Aleve
Adverse event in female receiving Rebif (Interferon Beta-1A)
Reported by a pharmacist from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Injection Site Necrosis, Injection Site Discolouration, Injection Site Erythema, Injection Site Urticaria, Injection Site Infection, Injection Site Pruritus
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 41 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 41 year old female, weighing 93.0 kg (204.6 pounds)
Adverse reactions / side effects: Contusion, Head Injury, Headache, Fall, Convulsion, Loss of Consciousness
Suspect drug(s):
Rebif
Dosage: 44 mcg, 3 in 1 weeks, subcutaneous
Indication: Multiple Sclerosis
Start date: 2006-01-01
End date: 2007-03-01
Rebif
Dosage: 44 mcg, 3 in 1 weeks, subcutaneous
Indication: Multiple Sclerosis
Start date: 2007-09-19
Other drugs received by patient: Metformin HCL; Lovastatin; Lortab; Premarin; Hydrochlorothiazide W / Triamterene (Dyazide); Amlodipine
Adverse event in 43 year old male receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 43 year old male
Adverse reactions / side effects: Retinal Ischaemia
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Oxycodone HCL; Zanaflex; Zomig
Adverse event in 48 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Intervertebral Disc Protrusion, Multiple Sclerosis, Nerve Root Compression
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif
Dosage: 22 mcg, 3 in 1 weeks, subcutaneous, 22 mcg, 3 in 1 weeks, subcutaneous, 22 mcg, 3 in 1 weeks, subcut
Indication: Multiple Sclerosis
Start date: 2006-07-25
End date: 2007-06-01
Rebif
Dosage: 22 mcg, 3 in 1 weeks, subcutaneous, 22 mcg, 3 in 1 weeks, subcutaneous, 22 mcg, 3 in 1 weeks, subcut
Indication: Multiple Sclerosis
Start date: 2007-07-01
End date: 2007-07-01
Rebif
Dosage: 22 mcg, 3 in 1 weeks, subcutaneous, 22 mcg, 3 in 1 weeks, subcutaneous, 22 mcg, 3 in 1 weeks, subcut
Indication: Multiple Sclerosis
Start date: 2007-07-01
Other drugs received by patient: Allegra (Fexofenadine Hydrochloride); Prevacid; Miralax; Xanax; Lorazepam
Adverse event in 50 year old male receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 50 year old male
Adverse reactions / side effects: Burning Sensation, Fatigue, Balance Disorder, Disturbance in Attention, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 58 year old male receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 58 year old male
Adverse reactions / side effects: Stent Occlusion, Coronary Artery Occlusion
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Lopressor; Lipitor; Aspirin
Adverse event in 45 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 45 year old female
Adverse reactions / side effects: Ovarian Cyst, Dysfunctional Uterine Bleeding, Cystitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 41 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 41 year old female
Adverse reactions / side effects: Dysgeusia, Abdominal Pain, Breast Pain, Throat Irritation, Gallbladder Disorder
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Tylenol (Tylenol)
Adverse event in 51 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 51 year old female
Adverse reactions / side effects: Pneumonia, Colon Cancer Recurrent, Cardiac Stress Test Abnormal, Dehydration
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 54 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female
Adverse reactions / side effects: Injection Site Erythema, Injection Site Pain, Benign Lung Neoplasm
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 74 year old female receiving Rebif (Interferon Beta-1A)
Reported by a physician from United States on 2007-10-29
Patient: 74 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Antidepressant (Antidepressants); Ditropan (Oxybutynin / 00538901 / ); Antibiotic (Antibiotics)
Adverse event in 49 year old female receiving Rebif (Interferon Beta-1A)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: 49 year old female, weighing 90.7 kg (199.6 pounds)
Adverse reactions / side effects: Pulmonary Hypertension
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Nortriptyline (Nortriptyline / 00006501 / ); Darvocet; Flexeril; Wellbutrin; Pravachol; Norvasc; Nitroglycerin; Prevacid
Adverse event in female receiving Rebif (Interferon Beta-1A)
Reported by a physician from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Coordination Abnormal, Gait Disturbance, Ill-Defined Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 51 year old female receiving Rebif (Interferon Beta-1A)
Reported by a physician from United States on 2007-10-29
Patient: 51 year old female
Adverse reactions / side effects: Incision Site Infection, Breast Cancer Female, Wound Infection Staphylococcal
Adverse event resulted in: life threatening event
Suspect drug(s):
Rebif
Dosage: 44 mcg, 3 in 1 weeks, not reported
Indication: Multiple Sclerosis
Start date: 2006-02-01
End date: 2006-03-01
Rebif
Dosage: 44 mcg, 3 in 1 weeks, not reported
Indication: Multiple Sclerosis
Start date: 2006-09-01
End date: 2007-08-08
Rebif
Dosage: 44 mcg, 3 in 1 weeks, not reported
Indication: Multiple Sclerosis
Start date: 2007-01-01
Adverse event in 44 year old female receiving Rebif (Interferon Beta-1A)
Reported by a consumer/non-health professional from Brazil on 2007-10-29
Patient: 44 year old female
Adverse reactions / side effects: Renal Failure, Head Injury, Kidney Infection, Fall, Multiple Sclerosis Relapse
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in male receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male
Adverse reactions / side effects: Body Temperature Increased, Fungal Cystitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 61 year old male receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: 61 year old male
Adverse reactions / side effects: Hand Fracture, Fall
Suspect drug(s):
Rebif (Interferon Beta-1A)
Adverse event in 58 year old male receiving Rebif (Interferon Beta-1A)
Reported by a physician from France on 2007-10-29
Patient: 58 year old male
Adverse reactions / side effects: Renal Impairment, Dyspnoea
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Advil; Ditropan (Oxybutynin / 00538901 / ); Amlodipine Besylate; Zoxan (Doxazosin / 00639301 / ); Eductyl (Eductyl); Transipeg (Transipeg / 01618701 / )
Adverse event in 27 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: 27 year old female
Adverse reactions / side effects: Abdominal Mass, Gastrointestinal Disorder, Abdominal Pain Upper
Suspect drug(s):
Rebif (Interferon Beta-1A)
Other drugs received by patient: Prevacid; Cyclobenzaprine; Mirapex; Trazodone HCL; Topamax; Imitrex; Klonopin; Senokot (Senna Alexandrina); Levothyroxine (Levothyroxine / 00068001 / )
Adverse event in 41 year old female receiving Rebif (Interferon Beta-1A)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: 41 year old female
Adverse reactions / side effects: White Blood Cell Count Decreased, Selective IGA Immunodeficiency, Bartholinitis, Selective IGG Subclass Deficiency, Sialoadenitis, Neutropenia, Pharyngitis Streptococcal, Escherichia Infection, Hypertension, Blood Immunoglobulin M Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Novantrone
Indication: Multiple Sclerosis
Start date: 2006-05-15
End date: 2007-01-10
Rebif
Dosage: 44 mcg, 3 in 1 weeks, subcutaneous
Indication: Multiple Sclerosis
Start date: 2005-10-03
Other drugs received by patient: Imipramine (Imipramine / 00053901 / ); Elmiron; Neurontin; Baclofen; Naltrexone (Naltrexone)
Adverse event in 48 year old female receiving Rebif (Interferon Beta-1A)
Reported by a consumer/non-health professional from France on 2007-10-29
Patient: 48 year old female, weighing 47.0 kg (103.4 pounds)
Adverse reactions / side effects: Pyomyositis, Wrong Technique in Drug Usage Process, Injection Site Reaction, Urinary Tract Infection, Septic Shock, Wound Infection Staphylococcal, Calculus Bladder
Adverse event resulted in: hospitalization
Suspect drug(s):
Rebif
Dosage: subcutaneous; 22 mcg, 3 in 1 weeks, subcutaneous
Indication: Multiple Sclerosis
End date: 2007-08-06
Rebif
Dosage: subcutaneous; 22 mcg, 3 in 1 weeks, subcutaneous
Indication: Multiple Sclerosis
Start date: 2007-01-01
|
